ASHG welcomed eight 2024–2026 Human Genetics Scholars who are recognized for their accomplishments and commitment to fostering DEI in human genetics and genomics.

This update in the health sector highlights major developments including DiaSorin's significant profit growth, GSK's RSV ...

Astra saw £14.4bn wiped off its value after Chinese media said dozens of managers were implicated in a scandal.

The biggest fallers on the FTSE 100 were Schroders, down 49.8p to 313.8p, AstraZeneca, down 928p to 10,114p, Hikma ...

European stocks closed broadly higher on Tuesday with investors largely making cautious moves, digesting mixed earnings updates and economic data, and looking ...

With a rich background in brand positioning, Laura brings a wealth of strategic experience partnering with renowned organizations including Keurig Dr Pepper, Nestle, American Cancer Society, Merck, ...

The growing demand for alopecia treatments is mainly driven by the rising global prevalence of alopecia, influenced by various factors, as well as increasing research and development efforts in ...

Heading into Moderna’s third-quarter earnings, investors and analysts will be watching to see how the Cambridge drugmaker ...

Shares of GSK PLC GSK dropped 1.59% to £13.92 Tuesday, on what proved to be an all-around poor trading session for the stock ...

When MRNA reports third-quarter earnings, investors will likely focus on the sales performance of its recently approved RSV ...

GSK has received Canadian approval for its respiratory syncytial virus vaccine in adults between 50 and 59, the company said ...

Premier Li Qiang's remarks demonstrate to the world the Chinese government's firm stance in advancing a higher level of ...